James A. Ruggles

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen et al. · American Journal of Health-System Pharmacy · 2005 · 438 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Fred W. Whitehouse, Davida Kruger, Mark Fineman et al. · Diabetes Care · 2002 · 260 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Crystal Structure of the Oxytricha nova Telomere End Binding Protein Complexed with Single Strand DNA

Martin P. Horvath, Viloya L Schweiker, Joanne M. Bevilacqua et al. · Cell · 1998 · 252 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Effect of Pramlintide on Weight in Overweight and Obese Insulin‐Treated Type 2 Diabetes Patients

Priscilla Hollander, David Maggs, James A. Ruggles et al. · Obesity Research · 2004 · 193 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Adjunctive Therapy with the Amylin Analogue Pramlintide Leads to a Combined Improvement in Glycemic and Weight Control in Insulin-Treated Subjects with Type 2 Diabetes

Robert E. Ratner, Laura L. Want, Mark Fineman et al. · Diabetes Technology & Therapeutics · 2002 · 154 citations

Medicine, Pharmacology, Pharmacotherapy +16